Pharmaceuticals

2025 Analysis: Opportunities and Risks in the Evolving Serum Market

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Are the Latest Market Insights for the Serum Industry?#_x000D_

In recent years, the antivirals market has experienced substantial expansion. It is projected to escalate from $106.64 billion in 2024 to $114.4 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Several factors such as the prevalence of viral diseases, public health issues, expiration of patents, and government incentives contributed to this growth during the historic period._x000D_

_x000D_

The market for antivirals is forecasted to experience robust expansion in the upcoming years, with projections estimating it to reach “$151.54 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. The impetus for this growth in the projected period can be linked to the advent of new viral threats and international health campaigns. The period also expects to witness significant trends such as technological progression, the rise of telemedicine and digital health, as well as the growth of personalized medicine._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp_x000D_

_x000D_

#What Forces Are Driving The Growth Of The Serum Industry?#_x000D_

An increased understanding of skin problems related to aging is anticipated to drive the serum market’s expansion. Skin conditions typically faced by an aging demographic, including wrinkles and facial movement lines, are referred to as age-related skin issues. Serums are effective in addressing these age-related skin concerns, such as dull skin, hyperpigmentation, dehydration, wrinkles, and sagging skin. They also help in balancing skin color, brightening skin, diminishing visible imperfections, and providing nourishment. For instance, data from Melanoma UK, a UK-based patient support and advocacy group, suggests that by 2025, melanoma skin cancer cases are expected to surge by 9% to a total of 19,513. Also, the fatalities as a result of this disease are likely to increase 13% to 3,119. By 2040, a staggering 22,886 individuals are expected to be diagnosed with melanoma skin cancer. Therefore, the escalating consciousness about age-related skin issues is fueling the boom in the serum market._x000D_

_x000D_

The antivirals market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Branded, Generic_x000D_

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes _x000D_

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV) _x000D_

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals_x000D_

_x000D_

#How Are Key Trends Driving Expansion In The Serum Industry?#_x000D_

Leading businesses in the antiviral market are concentrating their efforts on creating novel therapies, such as oral antiviral treatments, aimed at enhancing patient adherence, improving accessibility, curbing healthcare expenditure, and providing more effective and convenient solutions for viral infection management. Oral antiviral treatments, which are medication taken orally to combat viral infections, function by hindering the replication or spread of viruses within the human body, hence reducing the infection’s intensity and period. For example, Pfizer, a US pharmaceutical company, announced the Food and Drug Administration’s endorsement of Paxlovid in May 2023. This event is noteworthy because Paxlovid, the first-ever orally administered antiviral treatment for adult COVID-19 patients, introduces a fresh approach to COVID-19 management, especially as the world prepares for the pandemic’s potential transition into an endemic phase. Paxlovid is particularly designed for adults with a mild to moderate case of COVID-19 and who are at a high risk of the disease worsening to a severe state, potentially leading to hospitalization or even death._x000D_

_x000D_

#Who Are The Primary Players Operating Across The Global Serum Market?#_x000D_

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc._x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report_x000D_

_x000D_

#Which Region Offers The Most Growth Potential For The Serum Market Through 2029?#_x000D_

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_